An attacker killed eight students and injured two others with a cleaver (NOT a gun) at an elementary school in Chaoyangpo village of Enshi city in the Hubei province of central China on September 3, 2019.
“China tightly restricts private gun ownership, making knives and homemade explosives the most common weapons in violent crimes.”
The attacker was released in June, 2018, after serving more than eight years in jail for attempted murder. We aren’t sure about China, but in the U.S. prison inmates are regularly dosed with dangerous psychiatric drugs known to cause violence and suicide.
As of this writing, the case is still under investigation and no motive has been found for the attacks. Not much additional information is available, so speculation abounds. Our own speculation is that the attacker was most probably given psychiatric drugs while incarcerated, drugs which are known to cause violence and suicide.
We do know that China’s Ministry of Public Security uses psychiatric involuntary commitment to remove dissidents from society.
“Given the enormous increases in psychiatric drug sales in China, there is little doubt that the pharmaceutical industry has landed a lucrative market, driven by a psychiatric community willing to deliberately politicize psychiatric labeling.”
Under China’s current system of compulsory mental health treatment, people can be sent to asylums for treatment against their will by blood relatives or spouses, and forcibly given harmful psychiatric drugs.
It has also been well documented that psychiatric torture occurs inside Chinese prisons, often conducted with the goal of securing a confession, even though the Chinese government has officially made obtaining confessions through the use of torture illegal.
Let’s just aim for the right target and get the actual data, shall we? At least in the U.S. we can contact our government officials and urge them to hold legislative hearings to fully investigate the correlation between psychiatric drugs, violence, and suicide. The U.S. Food and Drug Administration, representing the U.S. government’s interest in protecting citizens from harmful drugs, already says that antidepressants increase the risk of suicidal thinking and behavior; children and adolescents who are started on antidepressants should be observed closely for clinical worsening, suicidality, agitation, irritability, or unusual changes in behavior. And keep those meat cleavers away from kids on Prozac.
